Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

Market Cap	17.01B
Revenue (ttm)	980.37M
Net Income (ttm)	345.60M
Shares Out	523.58M
EPS (ttm)	0.66
PE Ratio	49.20
Forward PE	47.76
Dividend	0.24 (0.74%)
Ex-Dividend Date	Jul 8, 2025

Volume	14,084,311
Average Volume	17,205,790
Open	29.70
Previous Close	32.03
Day's Range	29.70 - 32.60
52-Week Range	16.32 - 34.98
Beta	0.87
RSI	69.40
Earnings Date	Aug 22, 2025

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kit; and Changdian II, a house dust mite skin prick diagnosis kit. It also involved in the research and development of stem cells and medical artificial...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2002
• Employees: 1,679
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300357

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.